Page 155 - Read Online
P. 155

Sharma et al. Microbiome Res Rep 2024;3:3  https://dx.doi.org/10.20517/mrr.2023.51  Page 15 of 17

               15.       Kavanaugh DW, O’Callaghan J, Buttó LF, et al. Exposure of Bifidobacterium longum subsp. infantis to milk oligosaccharides
                    increases adhesion to epithelial cells and induces a substantial transcriptional response. PLoS One 2013;8:e67224.  DOI  PubMed
                    PMC
               16.       Foroni E, Serafini F, Amidani D, et al. Genetic analysis and morphological identification of pilus-like structures in members of the
                    genus Bifidobacterium. Microb Cell Fact 2011;10 Suppl 1:S16.  DOI  PubMed  PMC
               17.       Sarkar A, Mandal S. Bifidobacteria-insight into clinical outcomes and mechanisms of its probiotic action. Microbiol Res
                    2016;192:159-71.  DOI  PubMed
               18.       Alp G, Aslim B. Relationship between the resistance to bile salts and low pH with exopolysaccharide (EPS) production of
                    Bifidobacterium spp. isolated from infants feces and breast milk. Anaerobe 2010;16:101-5.  DOI
               19.       Chiu Y, Tsai J, Lin S, Chotirosvakin C, Lin M. Characterisation of bifidobacteria with immunomodulatory properties isolated from
                    human breast milk. J Funct Foods 2014;7:700-8.  DOI
               20.       Bermudez-Brito M, Muñoz-Quezada S, Gomez-Llorente C, et al. Cell-free culture supernatant of Bifidobacterium breve CNCM I-
                    4035 decreases pro-inflammatory cytokines in human dendritic cells challenged with Salmonella typhi through TLR activation. PLoS
                    One 2013;8:e59370.  DOI  PubMed  PMC
               21.       Meng H, Ba Z, Lee Y, et al. Consumption of Bifidobacterium animalis subsp. lactis BB-12 in yogurt reduced expression of TLR-2 on
                    peripheral blood-derived monocytes and pro-inflammatory cytokine secretion in young adults. Eur J Nutr 2017;56:649-61.  DOI
               22.       Mortaz E, Adcock IM, Ricciardolo FL, et al. Anti-inflammatory effects of lactobacillus rahmnosus and Bifidobacterium breve on
                    cigarette smoke activated human macrophages. PLoS One 2015;10:e0136455.  DOI  PubMed  PMC
               23.       Yang X, Gao XC, Liu J, Ren HY. Effect of EPEC endotoxin and bifidobacteria on intestinal barrier function through modulation of
                    toll-like receptor 2 and toll-like receptor 4 expression in intestinal epithelial cell-18. World J Gastroentero 2017;23:4744-51.  DOI
               24.       Becerra  JE,  Coll-Marqués  JM,  Rodríguez-Díaz  J,  Monedero  V,  Yebra  MJ.  Preparative  scale  purification  of  fucosyl-N-
                    acetylglucosamine disaccharides and their evaluation as potential prebiotics and antiadhesins. Appl Microbiol Biotechnol
                    2015;99:7165-76.  DOI  PubMed
               25.       Chichlowski M, De Lartigue G, German JB, Raybould HE, Mills DA. Bifidobacteria isolated from infants and cultured on human
                    milk oligosaccharides affect intestinal epithelial function. J Pediatr Gastroenterol Nutr 2012;55:321-7.  DOI  PubMed  PMC
               26.       Collado MC, Gueimonde M, Sanz Y, Salminen S. Adhesion properties and competitive pathogen exclusion ability of bifidobacteria
                    with acquired acid resistance. J Food Prot 2006;69:1675-9.  DOI  PubMed
               27.       Vazquez-Gutierrez P, Lacroix C, Jaeggi T, Zeder C, Zimmerman MB, Chassard C. Bifidobacteria strains isolated from stools of iron
                    deficient infants can efficiently sequester iron. BMC Microbiol 2015;15:3.  DOI  PubMed  PMC
               28.       Liévin V, Peiffer I, Hudault S, et al. Bifidobacterium strains from resident infant human gastrointestinal microflora exert
                    antimicrobial activity. Gut 2000;47:646-52.  DOI  PubMed  PMC
               29.       Bali V, Panesar PS, Bera MB, Kennedy JF. Bacteriocins: recent trends and potential applications. Crit Rev Food Sci Nutr
                    2016;56:817-34.  DOI  PubMed
               30.       Liu G, Ren L, Song Z, Wang C, Sun B. Purification and characteristics of bifidocin A, a novel bacteriocin produced by
                    Bifidobacterium animals BB04 from centenarians’ intestine. Food Control 2015;50:889-95.  DOI
               31.      Klaenhammer TR. Genetics of bacteriocins produced by lactic acid bacteria. FEMS Microbiol Rev 1993;12:39-85.  PubMed
               32.
                           Collado MC, González A, González R, Hernández M, Ferrús MA, Sanz Y. Antimicrobial peptides are among the antagonistic
                    metabolites produced by Bifidobacterium against Helicobacter pylori. Int J Antimicrob Agents 2005;25:385-91.  DOI
               33.       Heravi F, Hu H. Bifidobacterium: host-microbiome interaction and mechanism of action in preventing common gut-microbiota-
                    associated complications in preterm infants: a narrative review. Nutrients 2023;15:709.  DOI  PubMed  PMC
               34.       Fukuda S, Toh H, Hase K, et al. Bifidobacteria can protect from enteropathogenic infection through production of acetate. Nature
                    2011;469:543-7.  DOI
               35.       Matsuki T, Pédron T, Regnault B, Mulet C, Hara T, Sansonetti PJ. Epithelial cell proliferation arrest induced by lactate and acetate
                    from Lactobacillus casei and Bifidobacterium breve. PLoS One 2013;8:e63053.  DOI  PubMed  PMC
               36.       Bindels LB, Porporato P, Dewulf EM, et al. Gut microbiota-derived propionate reduces cancer cell proliferation in the liver. Br J
                    Cancer 2012;107:1337-44.  DOI  PubMed  PMC
               37.       Ravishankar RV, Jamuna AB. Beneficial microbes in fermented and functional foods. Boca Raton, FL: CRC Press; 2015. Available
                    from: https://www.taylorfrancis.com/books/edit/10.1201/b17912/beneficial-microbes-fermented-functional-foods-ravishankar-rai-
                    jamuna-bai. [Last accessed on 31 Oct 2023].
               38.       Vancamelbeke M, Vermeire S. The intestinal barrier: a fundamental role in health and disease. Expert Rev Gastroenterol Hepatol
                    2017;11:821-34.  DOI  PubMed  PMC
               39.       Hsieh CY, Osaka T, Moriyama E, Date Y, Kikuchi J, Tsuneda S. Strengthening of the intestinal epithelial tight junction by
                    Bifidobacterium bifidum. Physiol Rep 2015;3:e12327.  DOI  PubMed  PMC
               40.       Ulluwishewa D, Anderson RC, McNabb WC, Moughan PJ, Wells JM, Roy NC. Regulation of tight junction permeability by
                    intestinal bacteria and dietary components. J Nutr 2011;141:769-76.  DOI  PubMed
               41.       Ling X, Linglong P, Weixia D, Hong W. Protective effects of Bifidobacterium on intestinal barrier function in LPS-induced
                    enterocyte barrier injury of Caco-2 monolayers and in a rat NEC model. PLoS One 2016;11:e0161635.  DOI  PubMed  PMC
               42.       Al-Sadi R, Dharmaprakash V, Nighot P, et al. Bifidobacterium bifidum enhances the intestinal epithelial tight junction barrier and
                    protects against intestinal inflammation by targeting the toll-like receptor-2 pathway in an NF-κB-independent manner. Int J Mol Sci
   150   151   152   153   154   155   156   157   158   159   160